The University of Minnesota has announced the purchase of a start-up company sparked by faculty research. The enterprise, CoreBiome, was founded in 2017 as part of the Office of Technology Commercialization's efforts to widen the availability of therapies and products developed at the University. According to the release, "CoreBiome provides analysis of microbial communities for human health, agricultural and environmental applications." The company acquiring CoreBiome, OraSure Technologies, is "a leader in the development, manufacturing and distribution of point-of-care diagnostic and collection devices to detect or diagnose critical medical conditions." The University is a pioneer in microbiome research; the technology behind CoreBiome was developed by researchers Dan Knights, Daryl Gohl, and Kenneth Beckman, who is Director of the University of Minnesota Genomics Center, a Consortium member.